Investors Research Corp Novo Nordisk A S Transaction History

Investors Research Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $3,486 - $4,601	-34 Reduced 51.52%	32 $4,000
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $3,048 - $3,741	32 Added 94.12%	66 $7,000
Q2 2022 Jul 21, 2022	BUY	$103.24 - $121.81 $3,510 - $4,141	34 New	34 $4,000
Q2 2020 Jul 21, 2020	SELL	$58.54 - $67.94 $499,346 - $579,528	-8,530 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$49.46 - $64.78 $9,892 - $12,956	-200 Reduced 2.29%	8,530 $514,000
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $14,028 - $15,372	-300 Reduced 3.32%	8,730 $412,000
Q2 2018 Aug 10, 2018	BUY	$44.29 - $50.42 $1,328 - $1,512	30 Added 0.33%	9,030 $416,000
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $427,770 - $483,570	9,000	9,000 $483,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.